Stock Earnings

Question 1

Collplant Biotechnologies Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Collplant Biotechnologies Ltd'in toplam varlıkları $18 olup, net loss $-16'dir.

Question 2

CLGN'ün temel finansal oranları nelerdir?

Accepted Answer

Collplant Biotechnologies Ltd'in cari oranı 3.6, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Collplant Biotechnologies Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Collplant Biotechnologies Ltd largest revenue segment is Licensing Agreement, at a revenue of 10,000,000 in the most earnings release.For geography, United States is the primary market for Collplant Biotechnologies Ltd, at a revenue of 10,839,000.

Question 4

Collplant Biotechnologies Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Collplant Biotechnologies Ltd'in net loss $-16'dir.

Question 5

Collplant Biotechnologies Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Collplant Biotechnologies Ltd'in yükümlülüğü 5'dir.

Question 6

Collplant Biotechnologies Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Collplant Biotechnologies Ltd'in toplam tedavüldeki hisse sayısı 11.45'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	0	10	0	15	6
Revenue Growth (YoY)	--	-100%	--	-100%	150%	200%
Cost of Revenue	0	1	1	0	1	3
Gross Profit	1	0	9	0	14	3
Selling, General & Admin	5	5	5	6	5	4
Research & Development	9	10	10	10	7	3
Operating Expenses	14	16	16	17	13	8
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-13	-16	-7	-16	0	-5
Income Tax Expense	--	--	--	--	--	--
Net Income	-13	-16	-7	-16	0	-5
Net Income Growth	-24%	129%	-56%	--	-100%	-55%
Shares Outstanding (Diluted)	11.84	11.45	11.38	11.03	11.97	6.89
Shares Change (YoY)	3%	1%	3%	-8%	74%	38%
EPS (Diluted)	-1.09	-1.45	-0.61	-1.53	0.02	-0.84
EPS Growth	-28.99%	135%	-60%	-7,750%	-102%	-63%
Free Cash Flow	-10	-14	-3	-15	0	-4
Free Cash Flow Per Share	-0.84	-1.22	-0.26	-1.35	0	-0.58
Gross Margin	50%	0%	90%	0%	93.33%	50%
Operating Margin	-650%	0%	-60%	0%	0%	-83.33%
Profit Margin	-650%	0%	-70%	0%	0%	-83.33%
Free Cash Flow Margin	-500%	0%	-30%	0%	0%	-66.66%
EBITDA	-13	-15	-5	-15	0	-5
EBITDA Margin	-650%	0%	-50%	0%	0%	-83.33%
D&A For EBITDA	0	1	1	1	0	0
EBIT	-13	-16	-6	-16	0	-5
EBIT Margin	-650%	0%	-60%	0%	0%	-83.33%
Effective Tax Rate	--	--	--	--	--	--

Collplant Biotechnologies Ltd (CLGN) Price

CLGN Stock Price Chart

CLGN Income

Follow-Up Questions